Filling the need for trusted information on national health issues…

Trending on kff King v. Burwell Medicaid Expansion Tax Season & the ACA

Kaiser Daily Global Health Policy ReportClinical Research/R&D Search Results « » The Henry J. Kaiser Family Foundation

Clinical Research/R&D

  • your selections
Clear Search

Filter Results

date

Tags

  • results
USAID’s Report To Congress On Health-Related R&D Shows Progress, Challenges

Center for Global Health Policy’s “Science Speaks”: USAID report and launch show varying degrees of progress on global health research goals Antigone Barton, writer and editor of “Science Speaks” and senior communications officer at the Center for Global Health Policy, discusses highlights from the launch of USAID’s Health-Related Research and…

Researchers Hit Snags In Testing Ebola Treatments, Vaccines

Al Jazeera America: Why we’re still waiting on an Ebola vaccine “Since Ebola hit [Freetown, Sierra Leone,] last summer, nurses at Connaught Hospital have put their lives on the line by working with patients at risk of the deadly disease. Now researchers aim to recruit them as well as ambulance…

Carlos Slim Foundation Receives Texas Children’s Hospital Award, Recognized For NTD Vaccine Research

Forbes: Carlos Slim’s Foundation Recognized For Work On Health, Research To Develop Anti-Chagas Vaccine “Texas Children’s Hospital, a Houston-based not-for-profit health care organization, announced Monday that the Carlos Slim Foundation is this year’s recipient of the 2015 International Recognition Award of their 25th International Colloquium. … The foundation said that…

Passage Of ‘Innovation Act’ By Congress Would Harm Drug Development

Roll Call: The Wrong Direction on Patents Todd E. Gillenwater, senior vice president of Public Policy at the California Healthcare Institute “…Poorly conceived and hastily written legislation can stunt innovation, harm the economy, and even cost lives. Unfortunately, this is the case with the recently reintroduced Innovation Act (H.R. 9).…

Gates Foundation To Invest $52M In German Biotech Company, To Work Together To Develop Infectious Disease Vaccines

Reuters: Gates Foundation makes its biggest-ever equity investment in German biotech “The Bill & Melinda Gates Foundation said it would invest $52 million in CureVac, a German biotechnology company that develops vaccines and immunotherapies, marking the foundation’s biggest-ever equity investment. … The foundation will also fund multiple projects developing vaccines…

Community Involvement Important Factor In HIV Prevention Clinical Trials

Al Jazeera America: Blame research design for failed HIV study Ida Susser, professor of anthropology at the CUNY Graduate Center and adjunct professor of sociomedical sciences at the HIV Center at Columbia University “…The VOICE study appeared to lack sufficient community involvement. … The high HIV incidence observed in the…

IBT Examines Strategies Aimed At Promoting Antibiotic Drug Development

International Business Times: Antibiotic Resistance: Why Aren’t Drug Companies Developing New Medicines To Stop Superbugs? “…[A]s many as 10 million people a year could die from antibiotic-resistant bacteria worldwide by 2050 if new treatments are not discovered, according to a recent report from the Review on Antimicrobial Resistance. … Despite…